-
Rituximab in
combination with
hyaluronidase human, sold
under the
brand names MabThera SC and
Rituxan Hycela, is used to
treat follicular lymphoma,
diffuse large...
-
cancer Avastin 6847 6686 10
rituximab non-Hodgkin's
lymphoma Rituxan,
MabThera 6750 7298 11
rivaroxaban anticoagulant Xarelto 6589 6234 12 aflibercept...
-
Archived from the
original on
March 13, 2023.
Retrieved March 3, 2023. "
MabThera EPAR".
European Medicines Agency (EMA).
Archived from the
original on September...
- (Simulect),
cetuximab (Erbitux),
infliximab (Remicade) and
rituximab (
MabThera).
There are also
several examples of
chimerics currently in
clinical trials...
- (AMD).
Luxturna (voretigene neparvovec), for Leber's
congenital amaurosis.
MabThera (rituximab), for B-cell
chronic lymphocytic leukaemia (and
other haematological...
- In
combination with anti-CD20
monoclonal antibody rituximab (Rituxan,
Mabthera) it is
called R-DHAP or DHAP-R. [R]-DHAP
regimen consists of: Rituximab...
-
Emcure for
manufacturing its
blockbuster anticancer drugs Herceptin and
Mabthera in India.
Under this
programme the
cancer drugs shall be made available...
- ANCA-****ociated
Vasculitis Chronic lymphocytic leukemia 1997 2006 2011 1998 (as
MabThera) The
first monoclonal antibody for
cancer developed by IDEC,
prior to merging...
- When used as drugs, the
International Nonproprietary Names (INNs) end in -
mab. The
remaining syllables of the INNs, as well as the
column Source, are explained...
- NeoRecormon, erythropoietin),
Enbrel (etanercerpt),
Remicade (infliximab);
MabThera/Rituxin (rituximab), and
Herceptin (trastuzumab).
PEGylation is a big step...
